A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- ModernaTX, Inc.
- Study ID
- NCT05130437
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Propionic Acidemia
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - N/A
- Healthy Volunteers
- Not accepted
Interventions
- mRNA-3927 — BIOLOGICALmRNA-3927 dispersion for IV infusion
Study Details
The main purpose of this study is to evaluate the long-term safety of mRNA-3927 administered to participants with propionic acidemia (PA) who have previously participated in Study mRNA-3927-P101 (NCT04159103).
Key Dates
- Start date
- Nov 9, 2021
- Status verified
- Mar 2026
- Primary completion
- Dec 4, 2029
- Completion
- Dec 4, 2031
Study Design
- Enrollment
- 50 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: mRNA-3927Participants will receive the applicable dose identified during Study mRNA-3927-P101 (NCT04159103) on Day 1. The dose can be adjusted based on Sponsor recommendation.
Primary Outcome Measure
Number of Participants with Adverse Events (AEs), Serious AEs (SAEs), and AEs Leading to Discontinuation [ Time Frame: Baseline through End of Study Visit (up to 8 years) ]
Central Contacts
- Moderna WeCare Team1-866-663-3762
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ronald Reagan UCLA Medical Center | Los Angeles | California | 90095 | - |
| University of Stanford Medical Center | Palo Alto | California | 94304-1503 | - |
| University of Michigan Hospitals | Ann Arbor | Michigan | 48109 | - |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | - |
| Duke University Medical System (Duke Health) | Durham | North Carolina | 27710 | - |
| The Children's Hospital of Philadelphia (CHOP) | Philadelphia | Pennsylvania | 19104 | - |
| Texas Children's Hospital | Houston | Texas | 77030 | - |
Find similar trials in Los Angeles, CA
By research site
Ronald Reagan UCLA Medical Center· Los Angeles, CAUniversity of Stanford Medical Center· Palo Alto, CAUniversity of Michigan Hospitals· Ann Arbor, MIIcahn School of Medicine at Mount Sinai· New York, NYDuke University Medical System (Duke Health)· Durham, NCThe Children's Hospital of Philadelphia (CHOP)· Philadelphia, PA
Related Studies
- Natural History, Physiology, Microbiome and Biochemistry Studies of Propionic AcidemiaRecruiting · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- Open-Label Study of mRNA-3927 in Participants With Propionic AcidemiaPHASE1/PHASE2 · Recruiting · ModernaTX, Inc. · Los Angeles, California
- An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and PediatricsRecruiting · RECORDATI GROUP · Washington D.C., District of Columbia